Insider / AMGEN INC
Austin Wanda M
Director at AMGEN INC
- Company
- AMGEN INC
- First filing on record
- February 3, 2026
- Latest trade on record
- May 27, 2026
- SEC filings
- EDGAR ↗
Austin Wanda M, Director at AMGEN INC, has disclosed 5 transactions in CVX, AMGN, AAPL since February 3, 2026: 0 purchases (0 open-market buys) and 0 sales, worth about $0 at the reported prices. The latest was filed May 29, 2026, 2 days after the trade.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Austin Wanda M reported 5 transactions that were neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
0 of 4 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 3 | 3,076 | — |
| M | Option exercise or conversion | 2 | 2,510 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 5 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| CVX | Other A | May 27, 2026 | May 29, 2026 | 2d | 1,272 | — | — | Form 4 ↗ | ||
| AMGN | Other A | May 19, 2026 | May 21, 2026 | 2d | 665 | — | — | Form 4 ↗ | ||
| AAPL | Other A | February 24, 2026 | February 26, 2026 | 2d | 1,139 | — | — | derivative | Form 4 ↗ | |
| AAPL | Option / conversion M | February 1, 2026 | February 3, 2026 | 2d | 1,255 | — | — | derivative | Form 4 ↗ | |
| AAPL | Option / conversion M | February 1, 2026 | February 3, 2026 | 2d | 1,255 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| May 29, 2026 | Form 4 | 0000093410-26-000127 | 1 | published | EDGAR ↗ |
| May 21, 2026 | Form 4 | 0000318154-26-000098 | 1 | published | EDGAR ↗ |
| February 26, 2026 | Form 4 | 0001690882-26-000004 | 1 | published | EDGAR ↗ |
| February 3, 2026 | Form 4 | 0001690882-26-000002 | 2 | published | EDGAR ↗ |
Other insiders at AMGEN INC
- Newstead Jennifer SVP, GC and Government Affairs 47 rows
- Pate R. Hewitt Chief Legal Officer 43 rows
- HESS JOHN B Director 40 rows
- BONNER EIMEAR P Chief Financial Officer 39 rows
- Wirth Michael K Chairman and CEO 39 rows
- Walz Andrew Benjamin President, DM&C 38 rows
- GUSTAVSON JEFF B President, New Energies 32 rows
- Booth Thomas Ryder Chief Technology & Eng Ofr 31 rows
- COOK TIMOTHY D Executive Chair 31 rows
- NELSON MARK A Vice Chairman 28 rows
Everyone on file, with contracts and lobbying under the company's name: AMGEN INC.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 4 | 5 | February 3, 2026 | May 29, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.